Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 11(1): 22511, 2021 11 18.
Artigo em Inglês | MEDLINE | ID: mdl-34795372

RESUMO

Atherosclerotic cardiovascular disease (ACVD) is a lipid-driven inflammatory disease and one of the leading causes of death worldwide. Lipid deposits in the arterial wall lead to the formation of plaques that involve lipid oxidation, cellular necrosis, and complement activation, resulting in inflammation and thrombosis. The present study found that homozygous deletion of the CFHR1 gene, which encodes the plasma complement protein factor H-related protein 1 (FHR-1), was protective in two cohorts of patients with ACVD, suggesting that FHR-1 accelerates inflammation and exacerbates the disease. To test this hypothesis, FHR-1 was isolated from human plasma and was found to circulate on extracellular vesicles and to be deposited in atherosclerotic plaques. Surface-bound FHR-1 induced the expression of pro-inflammatory cytokines and tissue factor in both monocytes and neutrophils. Notably, plasma concentrations of FHR-1, but not of factor H, were significantly (p < 0.001) elevated in patients with ACVD, and correlated with the expression of the inflammation markers C-reactive protein, apolipoprotein serum amyloid protein A, and neopterin. FHR-1 expression also significantly correlated with plasma concentrations of low-density lipoprotein (LDL) (p < 0.0001) but not high-density lipoprotein (HDL). Taken together, these findings suggest that FHR-1 is associated with ACVD.


Assuntos
Aterosclerose/metabolismo , Doenças Cardiovasculares/metabolismo , Proteínas Inativadoras do Complemento C3b/fisiologia , Regulação da Expressão Gênica , Idoso , Cardiologia , Deleção Cromossômica , Ativação do Complemento , Proteínas Inativadoras do Complemento C3b/biossíntese , Proteínas Inativadoras do Complemento C3b/genética , Feminino , Perfilação da Expressão Gênica , Homozigoto , Humanos , Inflamação , Lipídeos/química , Masculino , Pessoa de Meia-Idade , Necrose , Oxigênio/química , Deleção de Sequência
2.
Sci Rep ; 6: 27414, 2016 06 09.
Artigo em Inglês | MEDLINE | ID: mdl-27278246

RESUMO

Historically, human diseases have been differentiated and categorized based on the organ system in which they primarily manifest. Recently, an alternative view is emerging that emphasizes that different diseases often have common underlying mechanisms and shared intermediate pathophenotypes, or endo(pheno)types. Within this framework, a specific disease's expression is a consequence of the interplay between the relevant endophenotypes and their local, organ-based environment. Important examples of such endophenotypes are inflammation, fibrosis, and thrombosis and their essential roles in many developing diseases. In this study, we construct endophenotype network models and explore their relation to different diseases in general and to cardiovascular diseases in particular. We identify the local neighborhoods (module) within the interconnected map of molecular components, i.e., the subnetworks of the human interactome that represent the inflammasome, thrombosome, and fibrosome. We find that these neighborhoods are highly overlapping and significantly enriched with disease-associated genes. In particular they are also enriched with differentially expressed genes linked to cardiovascular disease (risk). Finally, using proteomic data, we explore how macrophage activation contributes to our understanding of inflammatory processes and responses. The results of our analysis show that inflammatory responses initiate from within the cross-talk of the three identified endophenotypic modules.


Assuntos
Doenças Cardiovasculares/metabolismo , Endofenótipos/metabolismo , Fibrose/metabolismo , Redes Reguladoras de Genes/fisiologia , Humanos , Inflamassomos/metabolismo , Inflamação/metabolismo , Proteômica/métodos , Trombose/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...